IDEXX LABORATORIES INC /DE Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
IDEXX LABORATORIES INC /DE (IDXX) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $4.40 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2024-10-31
- 2024-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.40M.
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.40M.
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.40M.
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2024-09-30 | $4.40M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $4.40M 10-Q · filed 2024-10-31 |
| 2024-03-31 | $4.40M 10-Q · filed 2024-08-06 |
| 2023-12-31 | $0.00 10-Q · filed 2024-10-31 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-31 |
| 2023-06-30 | $120.00K 10-Q · filed 2024-10-31 |
| 2023-03-31 | $120.00K 10-Q · filed 2024-08-06 |
| 2022-12-31 | $120.00K 10-Q · filed 2024-10-31 |
| 2022-03-31 | $7.23M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $7.23M 10-K · filed 2024-02-22 |
| 2021-09-30 | $5.23M 10-Q · filed 2021-11-02 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |